ACT 2 Logo
TREATMENT · GI EFFECTS + MICROBIOMIX · HONEST POSITION

SIBO and Stool Testing: Why a Stool Panel Is the Wrong Test

This page exists to stop a specific purchase. A large share of the people who order a comprehensive stool panel do so because they suspect SIBO — small-intestinal bacterial overgrowth — and a stool panel cannot detect SIBO. Not "detects it imperfectly," not "gives a hint." It samples the wrong organ. Selling the panel to that person would be easy and would be wrong, so this page says what the right test is and how to get it.

The main page covers what the panel does measure, which is a great deal — just not this.

See if you're eligibleA short, confidential online assessment. Reviewed by a clinician.

What SIBO is

The small intestine — the long tube between stomach and colon where food is digested and absorbed — is normally almost sterile compared with the colon, kept that way by stomach acid, the sweeping motility of the gut between meals, and the valve at its far end. SIBO is what happens when that protection fails and colonic-type bacteria colonize the small intestine in large numbers. They ferment food before the body can absorb it, producing gas within an hour or so of eating, bloating, distension, diarrhea or alternating habit, and in established cases nutrient malabsorption — low B12, low iron, fat in the stool.

It happens to people whose protections are weakened: after abdominal surgery, on long-term acid suppression, with the slow motility of diabetes or hypothyroidism or opioid use, with scleroderma or Crohn's disease, and — the commonest association — alongside irritable bowel syndrome, where a meaningful minority test positive. It is over-diagnosed in some clinics and under-considered in others, and the test is the way through.

Why a stool panel cannot find it

Stool is the output of the colon. By the time a sample is produced, whatever was in the small intestine has passed through several meters of colon, been joined by the colon's own vastly larger bacterial population, and been transformed by it. The small-intestinal community is a fraction of a percent of what is in the sample and is not distinguishable from the colonic population by any analysis the panel runs — sequencing, culture or PCR. A stool panel can describe the colon in detail. It has no window on the small intestine at all.

Reports sometimes say otherwise, or imply it — "dysbiosis consistent with overgrowth," or a flag on a bacterial group that is "associated with SIBO." That is a colonic pattern being read as an upstream diagnosis, and no gastroenterology guideline accepts it. The main page's honest word on the evidence applies here in full.

What a breath test measures instead

The standard test for SIBO is a breath test. The person drinks a sugar solution — glucose or lactulose — and breathes into collection tubes at intervals over a few hours. If bacteria in the small intestine ferment the sugar, they produce hydrogen and, in some people, methane, which are absorbed into the blood and exhaled; the test measures both in the breath and reads the timing. Gas rising early, before the sugar could have reached the colon, indicates overgrowth in the small intestine. A methane-dominant pattern points to a related condition, intestinal methanogen overgrowth, which behaves differently and is associated with constipation rather than diarrhea.

The breath test is imperfect — its accuracy depends on the sugar used, the preparation, and how the timing is read, and false positives from fast transit are a known problem — but it is the accepted test, it is done at home with a mail-in kit, and it answers the question a stool panel cannot. The alternative, direct sampling of small-intestinal fluid through an endoscope, is the reference standard and is rarely necessary.

What we arrange

If the pattern on the bloating page points to SIBO — bloating and gas within an hour of eating, diarrhea or alternating habit, a risk factor from the list above — we say so and arrange a breath test rather than a stool panel.

If the breath test is positive, treatment is a gastroenterology matter — antibiotics chosen for the gut, addressing the cause of the overgrowth so it does not recur, and management of any malabsorption — and we refer. We do not treat SIBO. What we can do afterwards is the part that often gets missed: check the B12, iron and vitamin D that overgrowth depletes, on the baseline panel, and address them.

And if the breath test is negative, the stool panel becomes a reasonable next step — because the bloating still needs an explanation, and the panel is good at the causes that live downstream.

Questions

Frequently asked questions

  • No. Stool is the output of the colon; the small-intestinal bacteria are not distinguishable in it. A stool panel has no window on the small intestine.

  • A hydrogen and methane breath test after a glucose or lactulose drink, read for early gas rise. It is done at home with a mail-in kit. Direct sampling by endoscopy is the reference standard and rarely needed.

  • We arrange the breath test where the pattern points to it, rather than selling a stool panel that cannot answer the question. Treatment of a positive result is a gastroenterology referral.

  • Bloating and gas within an hour of eating, distension, diarrhea or alternating habit, and in established cases low B12, low iron or fatty stools. It overlaps heavily with IBS.

  • No. That is a colonic pattern being read as an upstream diagnosis. No guideline accepts a stool result as evidence of SIBO.

  • If the pattern suggests SIBO, the breath test. If it is negative, or the pattern points elsewhere, the stool panel — which is good at the causes that live in the colon.

Your next step

Where this fits in your plan

The GI Effects + Microbiomix page covers what the panel measures; this page is the one thing people most often buy it for that it cannot do. The bloating page sorts which test answers which pattern.

We measure first. Then we act.

References

  1. Pimentel M et al. ACG Clinical Guideline: small intestinal bacterial overgrowth. American Journal of Gastroenterology 2020;115:165–178.
  2. Rezaie A et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus. American Journal of Gastroenterology 2017;112:775–784.
  3. Quigley EMM, Murray JA, Pimentel M. AGA Clinical Practice Update on small intestinal bacterial overgrowth: expert review. Gastroenterology 2020;159:1526–1532.
  4. Shah A et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. American Journal of Gastroenterology 2020;115:190–201.
  5. Leite G et al. Mapping the segmental microbiomes in the human small bowel in comparison with stool: a REIMAGINE study. Digestive Diseases and Sciences 2020;65:2595–2604.

How we write and review our content

ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.

Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.

Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.

We measure first. Then we act.

Start with a baseline. Then decide about gi effects + microbiomix.